A quarter of our very elderly have undiagnosed treatable heart problems, research reveals

July 24, 2012

The very oldest in our society are missing out on simple heart treatments which can prolong and improve their quality of life, Newcastle heart experts say.

Studying a group of people aged 87 to 89 years old, the team of researchers at Newcastle University found that a routine test in the home revealed that around a quarter of them had undiagnosed heart problems which could be treated with established and cost-effective treatments.

In the study, funded by the British Heart Foundation (BHF), the team visited the homes of 376 people aged 87 to 89 years old and carried out echocardiograms -heart scans- using portable instruments.

Publishing today in Heart, they reveal that around a quarter (26%) of the people involved had a previously undiagnosed heart problem, in particular, impairment of left ventricular systolic function. Affected people's hearts do not contract strongly enough, which can leave them breathless and lead to heart failure. The condition is treatable with established drugs such as and .

BHF Professor Bernard Keavney, a at Newcastle University who led the study, admits to being taken aback at the extent of the problem: "We were surprised to discover just how many older people have heart problems. Many of these people could be treated with drugs that we know work, if their condition were recognised.

"Our research suggests that it might be practical to offer people over 85 who are breathless, an at home which would reveal these problems. Because this heart problem occurs so often at this age, home checks are likely to be cost-effective, whereas they wouldn't be in younger people In those people found to have hearts that were not pumping strongly enough on a home scan, medication could be considered. This would improve their and it's likely to slow their progression to heart failure.

"With heart failure, prevention is definitely a priority. Older patients coming into hospital with worsening is one of the largest sources of expenditure for the NHS. The number of people over 85 is already soaring, and this will continue for the foreseeable future. So anything we can do to improve the heart health of our oldest old is likely to have a big impact."

Taking part in the research were people involved in the Newcastle 85+ study, a unique study of the health of more than one thousand people from Newcastle and North Tyneside born in 1921.

"This is a group of people who are routinely excluded from trials of treatment on the grounds of their age," adds Dr. Joanna Collerton, Senior Clinical Research Associate at Newcastle's Institute for Ageing and Health and the study's co-lead author. "What we have discovered is that very many more people in this age group have heart problems compared to those in younger age groups so we need to think about more inclusive trials or trials focusing exclusively on older groups to ensure that as we face a growing older population we offer them the healthiest future."

Dr Shannon Amoils, Research Advisor at the BHF, said: "This study suggests that there are probably many more very elderly people in the community with than we previously supposed and many have symptoms like breathlessness that limits their daily activities. Despite this, their condition is often not recognised."

This research builds on Newcastle University's work as part of the Newcastle Initiative on Changing Age and the Newcastle institute for Social Renewal. This the University's response to the societal challenges including ageing, seeking new ways to make the most of the extensive opportunities associated with increasing human longevity, while at the same time solving some of the problems.

Explore further: Taking vitamin E does not impact women's heart failure risk

Related Stories

Taking vitamin E does not impact women's heart failure risk

March 20, 2012
Taking vitamin E supplements does not increase or decrease heart failure risk among women, according to a study in Circulation: Heart Failure, an American Heart Association journal.

'Broken heart syndrome' protects the heart from adrenaline overload

June 27, 2012
A condition that temporarily causes heart failure in people who experience severe stress might actually protect the heart from very high levels of adrenaline, according to a new study published in the journal Circulation. ...

Not faster, but longer -- new drug changes beat in treating heart failure

August 19, 2011
A new drug which offers a radically different approach to treating certain types of heart failure has been shown to improve cardiac function in heart failure patients in its first clinical trials.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.